DHCNL (Diversified Healthcare Trust 6.25% Senior Notes Due 2046)
Insider Trading Activity
Every open-market purchase and sale reported by DHCNL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | LISA HARRIS JONES | Director | A | — | — |
| 2026-06-12 | Alan L. Felder | Director | A | — | — |
| 2026-06-12 | Phyllis M. Hollis | Director | A | — | — |
| 2026-06-12 | Dawn K. Neher | Director | A | — | — |
| 2026-06-12 | JEFFREY P. SOMERS | Director | A | — | — |
| 2026-06-12 | Christopher J. Bilotto | President and CEO | A | — | — |
| 2026-06-12 | ADAM D. PORTNOY | Director | A | — | — |
| 2025-12-16 | Christopher J. Bilotto | President and CEO | Buy | — | — |
| 2025-09-18 | ADAM D. PORTNOY | Director | F | — | — |
| 2025-09-18 | Matthew C. Brown | CFO and Treasurer | F | — | — |
| 2025-09-18 | Christopher J. Bilotto | President and CEO | F | — | — |
| 2025-09-11 | Matthew C. Brown | CFO and Treasurer | A | — | — |
| 2025-09-11 | Christopher J. Bilotto | President and CEO | A | — | — |
| 2025-09-11 | ADAM D. PORTNOY | Director | A | — | — |
| 2025-06-02 | JEFFREY P. SOMERS | Director | A | — | — |
| 2025-06-02 | Alan L. Felder | Director | A | — | — |
| 2025-06-02 | Phyllis M. Hollis | Director | A | — | — |
| 2025-06-02 | Christopher J. Bilotto | President and CEO | A | — | — |
| 2025-06-02 | ADAM D. PORTNOY | Director | A | — | — |
| 2025-06-02 | Dawn K. Neher | Director | A | — | — |
| 2025-06-02 | LISA HARRIS JONES | Director | A | — | — |
| 2025-03-20 | Alan L. Felder | Director | A | — | — |
| 2024-11-14 | Matthew C. Brown | CFO and Treasurer | Buy | — | — |
| 2024-09-19 | Christopher J. Bilotto | President and CEO | F | — | — |
| 2024-09-19 | ADAM D. PORTNOY | Director | F | — | — |
| 2024-09-19 | Matthew C. Brown | CFO and Treasurer | F | — | — |
| 2024-09-13 | Christopher J. Bilotto | President and CEO | A | — | — |
| 2024-09-13 | Matthew C. Brown | CFO and Treasurer | A | — | — |
| 2024-09-13 | ADAM D. PORTNOY | Director | A | — | — |
| 2024-06-04 | LISA HARRIS JONES | Director | A | — | — |
| 2024-06-04 | Phyllis M. Hollis | Director | A | — | — |
| 2024-06-04 | Dawn K. Neher | Director | A | — | — |
| 2024-06-04 | JEFFREY P. SOMERS | Director | A | — | — |
| 2024-06-04 | Christopher J. Bilotto | President and CEO | A | — | — |
| 2024-06-04 | ADAM D. PORTNOY | Director | A | — | — |
| 2024-06-04 | JOHN L. HARRINGTON | Director | MIXED | — | — |
| 2023-09-26 | Phyllis M. Hollis | Director | A | — | — |
| 2023-09-20 | RICHARD W. SIEDEL JR. | CFO and Treasurer | F | — | — |
| 2023-09-20 | Jennifer F. Francis | President and CEO | F | — | — |
| 2023-09-15 | Jennifer F. Francis | President and CEO | A | — | — |
| 2023-06-14 | ADAM D. PORTNOY | Director | Buy | — | — |
| 2023-06-09 | ADAM D. PORTNOY | Director | Buy | — | — |
| 2023-06-06 | Daniel F. LePage | Director | A | — | — |
| 2023-06-06 | Jennifer F. Francis | President and CEO | A | — | — |
| 2023-06-06 | David A Pierce | Director | A | — | — |
| 2023-06-06 | ADAM D. PORTNOY | Director | MIXED | — | — |
| 2023-06-06 | LISA HARRIS JONES | Director | A | — | — |
| 2023-06-06 | JEFFREY P. SOMERS | Director | A | — | — |
| 2023-06-06 | JOHN L. HARRINGTON | Director | MIXED | — | — |
| 2023-06-01 | ADAM D. PORTNOY | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 23,677,576 | — |
| — | President and CEO | 279,246 | — |
| — | President and CEO | 256,153 | — |
| — | Director | 177,079 | — |
| — | Director | 170,287 | — |
| — | Director | 159,209 | — |
| — | Director | 134,074 | — |
| — | CFO and Treasurer | 113,954 | — |
| — | Director | 100,147 | — |
| — | CFO and Treasurer | 88,791 | — |
| — | Director | 78,579 | — |
| — | Director | 75,124 | — |
| — | Director | 72,448 | — |
| — | Director | 40,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DHCNL quote page; the site-wide leaderboard is on the insider transactions hub.